Parallax Volatility Advisers’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-100
Closed -$4.5K 3191
2022
Q4
$4.5K Buy
+100
New +$4.53K ﹤0.01% 2640
2022
Q3
Sell
-68,200
Closed -$4.04M 3363
2022
Q2
$4.04M Buy
+68,200
New +$5.6M ﹤0.01% 1052
2022
Q1
Sell
-10,100
Closed -$1.52M 3184
2021
Q4
$1.52M Sell
10,100
-1,900
-16% -$256K ﹤0.01% 1148
2021
Q3
$1.43M Buy
+12,000
New +$1.32M ﹤0.01% 1227
2021
Q2
Sell
-26,600
Closed -$2.35M 1716
2021
Q1
$2.35M Sell
26,600
-29,200
-52% -$2.71M 0.01% 656
2020
Q4
$5.34M Sell
55,800
-185,400
-77% -$19.1M 0.01% 928
2020
Q3
$27.4M Buy
241,200
+207,400
+614% +$21.8M 0.02% 610
2020
Q2
$3.35M Buy
33,800
+21,400
+173% +$1.71M ﹤0.01% 1245
2020
Q1
$793K Sell
12,400
-40,900
-77% -$2.87M ﹤0.01% 1563
2019
Q4
$3.18M Sell
53,300
-115,600
-68% -$7.13M ﹤0.01% 1091
2019
Q3
$9.96M Buy
168,900
+99,400
+143% +$6.34M 0.01% 593
2019
Q2
$4.48M Buy
69,500
+18,600
+37% +$1.2M ﹤0.01% 773
2019
Q1
$3.23M Sell
50,900
-185,200
-78% -$9.73M ﹤0.01% 826
2018
Q4
$8.96M Hold
236,100
0.01% 545
2018
Q3
$10.1M Buy
+236,100
New +$8.25M 0.01% 474

Other funds holding TNDM

Parallax Volatility Advisers's TNDM Position: Q2 2021 in Review

Parallax Volatility Advisers sold out of Tandem Diabetes Care (TNDM) in Q2 2021, closing a stake of 232 shares — an estimated $20K sold.

Parallax Volatility Advisers first reported a position in TNDM in Q3 2018 and held it in 10 quarters. The position peaked at $3.83M in Q3 2020. 303 funds tracked by Wall St. Rank hold TNDM as of Q2 2021.

  • Parallax Volatility Advisers reported no remaining Tandem Diabetes Care position as of Q2 2021 after selling out during the quarter.
  • Parallax Volatility Advisers sold 232 Tandem Diabetes Care shares in Q2 2021, an estimated $20K.
  • Parallax Volatility Advisers first reported a position in Tandem Diabetes Care in Q3 2018 and held it in 10 quarters.
  • Parallax Volatility Advisers's Tandem Diabetes Care position peaked at $3.83M in Q3 2020.
  • 303 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2021.

Based on Parallax Volatility Advisers's 13F filing for Q2 2021, filed 16 Aug 2021.